MEDACTA GROUP SA |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.60 CHF | -2.16% |
|
-2.34% | -13.54% |
| Sep. 25 | Swiss Market Index Advances Ahead of SNB's Rate Decision Day | MT |
| Sep. 25 | Medacta Group SA - Analyst/Investor Day |
Projected Income Statement: Medacta Group SA
| Fiscal Period: Dicembre | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 310.6 | 302.5 | 363.1 | 437.1 | 510.8 | 587.8 | 665.7 | 745.6 |
| Change | - | -2.61% | 20.04% | 20.38% | 16.85% | 15.07% | 13.26% | 12.01% |
| EBITDA 1 | 91.5 | 88.1 | 107.1 | 120.4 | 132.9 | 155 | 180.7 | 205.7 |
| Change | - | -3.72% | 21.59% | 12.44% | 10.32% | 16.67% | 16.56% | 13.83% |
| EBIT 1 | 57.81 | 51.08 | 66.68 | 68.94 | 75.72 | 90.49 | 107.1 | 121.9 |
| Change | - | -11.65% | 30.56% | 3.38% | 9.83% | 19.51% | 18.38% | 13.81% |
| Interest Paid 1 | -5.981 | -9.5 | -3.326 | -3.663 | -15.72 | -2.35 | -5.1 | -4.6 |
| Earnings before Tax (EBT) 1 | 13.63 | 39.9 | - | 54.79 | 58.73 | 84.07 | 101 | 118.5 |
| Change | - | 192.69% | -100% | - | 7.18% | 43.15% | 20.14% | 17.29% |
| Net income 1 | 11.86 | 37.1 | 51.52 | 46.25 | 47.36 | 72.27 | 85.65 | 99.82 |
| Change | - | 212.84% | 38.87% | -10.23% | 2.41% | 52.6% | 18.51% | 16.53% |
| Announcement Date | 4/6/20 | 3/30/21 | 3/11/22 | 3/17/23 | 3/13/24 | - | - | - |
1EUR in Million
Estimates
Forecast Balance Sheet: Medacta Group SA
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 106 | 83.3 | 65.3 | 112 | 135 | 157 | 150 | 131 |
| Change | - | -21.42% | -21.61% | 71.52% | 20.54% | 16.12% | -4.46% | -12.67% |
| Announcement Date | 4/6/20 | 3/30/21 | 3/11/22 | 3/17/23 | 3/13/24 | - | - | - |
1EUR in Million
Estimates
Cash Flow Forecast: Medacta Group SA
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 41.47 | 34.2 | 52.04 | 63.16 | 71.24 | 90.22 | 96.6 | 103.1 |
| Change | - | -17.54% | 52.17% | 21.36% | 12.79% | 26.65% | 7.07% | 6.74% |
| Free Cash Flow (FCF) 1 | 0.891 | 25.4 | 7.57 | 21.6 | 6.664 | 9.5 | 33.67 | 44.13 |
| Change | - | 2,750.73% | -70.2% | 185.34% | -69.15% | 42.56% | 254.39% | 31.09% |
| Announcement Date | 4/6/20 | 3/30/21 | 3/11/22 | 3/17/23 | 3/13/24 | - | - | - |
1EUR in Million
Estimates
Forecast Financial Ratios: Medacta Group SA
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
| EBITDA Margin (%) | 29.46% | 29.12% | 29.5% | 27.56% | 26.02% | 26.38% | 27.15% | 27.59% |
| EBIT Margin (%) | 18.61% | 16.88% | 18.36% | 15.77% | 14.82% | 15.4% | 16.09% | 16.35% |
| EBT Margin (%) | 4.39% | 13.19% | - | 12.53% | 11.5% | 14.3% | 15.17% | 15.89% |
| Net margin (%) | 3.82% | 12.26% | 14.19% | 10.58% | 9.27% | 12.3% | 12.87% | 13.39% |
| FCF margin (%) | 0.29% | 8.4% | 2.08% | 4.94% | 1.3% | 1.62% | 5.06% | 5.92% |
| FCF / Net Income (%) | 7.51% | 68.46% | 14.69% | 46.7% | 14.07% | 13.14% | 39.31% | 44.22% |
Profitability | ||||||||
| ROA | 11.59% | 8.68% | 12.6% | 8.61% | - | - | - | - |
| ROE | 42.48% | 25.76% | 30.1% | 18.46% | 15.66% | 20.32% | 19.71% | 19.34% |
Financial Health | ||||||||
| Leverage (Debt/EBITDA) | 1.15x | 0.95x | 0.61x | 0.93x | 1.02x | 1.02x | 0.83x | 0.64x |
| Debt / Free cash flow | 118.52x | 3.28x | 8.62x | 5.17x | 20.29x | 16.58x | 4.45x | 2.96x |
Capital Intensity | ||||||||
| CAPEX / Current Assets (%) | 13.35% | 11.31% | 14.33% | 14.45% | 13.95% | 15.35% | 14.51% | 13.83% |
| CAPEX / EBITDA (%) | 45.33% | 38.82% | 48.58% | 52.44% | 53.61% | 58.2% | 53.46% | 50.13% |
| CAPEX / FCF (%) | 4,654.77% | 134.65% | 687.48% | 292.4% | 1,069.01% | 949.72% | 286.94% | 233.65% |
Items per share | ||||||||
| Cash flow per share 1 | - | 2.98 | 2.7 | 3.676 | 3.758 | 5.456 | 6.994 | 7.826 |
| Change | - | - | -9.38% | 36.16% | 2.22% | 45.17% | 28.19% | 11.91% |
| Dividend per Share 1 | - | - | 0.54 | 0.54 | 0.55 | 0.7654 | 0.9048 | 1.022 |
| Change | - | - | - | 0% | 1.85% | 39.16% | 18.21% | 12.97% |
| Book Value Per Share 1 | 6.162 | 8.236 | 11.32 | 13.76 | 16.56 | 19.85 | 23.55 | 27.84 |
| Change | - | 33.66% | 37.45% | 21.56% | 20.36% | 19.84% | 18.67% | 18.18% |
| EPS 1 | 0.59 | 1.85 | 2.58 | 2.31 | 2.37 | 3.629 | 4.294 | 5.006 |
| Change | - | 213.56% | 39.46% | -10.47% | 2.6% | 53.1% | 18.35% | 16.57% |
| Nbr of stocks (in thousands) | 20,000 | 20,000 | 19,997 | 19,979 | 19,958 | 19,952 | 19,952 | 19,952 |
| Announcement Date | 4/6/20 | 3/30/21 | 3/11/22 | 3/17/23 | 3/13/24 | - | - | - |
1EUR
Estimates
| 2024 * | 2025 * | |
|---|---|---|
| P/E ratio | 32.9x | 27.8x |
| PBR | 6.01x | 5.07x |
| EV / Sales | 4.32x | 3.8x |
| Yield | 0.64% | 0.76% |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
119.32EUR
Average target price
150.17EUR
Spread / Average Target
+25.85%
Annual profits - Rate of surprise
- Stock Market
- Equities
- MOVE Stock
- Financials Medacta Group SA